In Vitro Induction of Antibody Secretion of Primary B-cell Chronic Lymphocytic Leukaemia Cells

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2014 Sep 11

PMID 25204568

Citations 6

Authors

R Hoogeboom

R J A Reinten

J-J Schot

J E J Guikema

R J Bende

C J M van Noesel

Affiliations

Soon will be listed here.

Citing Articles

Distinct groups of autoantigens as drivers of ocular adnexal MALT lymphoma pathogenesis.

Bende R, Donner N, Wormhoudt T, Beentjes A, Scantlebery A, Grobben M Life Sci Alliance. 2024; 7(9).

PMID: 38977312 PMC: 11231493. DOI: 10.26508/lsa.202402841.

A Major Subset of Mutated CLL Expresses Affinity-selected and Functionally Proficient Rheumatoid Factors.

Janssen J, Donner N, Li Z, Wormhoudt T, Wagner K, Guikema J Hemasphere. 2021; 5(4):e550.

PMID: 33778415 PMC: 7990012. DOI: 10.1097/HS9.0000000000000550.

Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.

Darwiche W, Gubler B, Marolleau J, Ghamlouch H Front Immunol. 2018; 9:683.

PMID: 29670635 PMC: 5893869. DOI: 10.3389/fimmu.2018.00683.

Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells.

Fonte E, Vilia M, Reverberi D, Sana I, Scarfo L, Ranghetti P Haematologica. 2017; 102(11):1901-1912.

PMID: 28775123 PMC: 5664394. DOI: 10.3324/haematol.2017.165878.

Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.

Comor L, Dolinska S, Bhide K, Pulzova L, Jimenez-Munguia I, Bencurova E Microb Cell Fact. 2017; 16(1):13.

PMID: 28114943 PMC: 5259998. DOI: 10.1186/s12934-017-0630-z.

References

Hoogeboom R, van Kessel K, Hochstenbach F, Wormhoudt T, Reinten R, Wagner K . A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. J Exp Med. 2013; 210(1):59-70. PMC: 3549718. DOI: 10.1084/jem.20121801. View

Lanemo Myhrinder A, Hellqvist E, Sidorova E, Soderberg A, Baxendale H, Dahle C . A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 2008; 111(7):3838-48. DOI: 10.1182/blood-2007-11-125450. View

Messmer B, Albesiano E, Efremov D, Ghiotto F, Allen S, Kolitz J . Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004; 200(4):519-25. PMC: 2211936. DOI: 10.1084/jem.20040544. View

Hwang K, Chen X, Kozink D, Gustilo M, Marshall D, Whitesides J . Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells. Blood. 2011; 119(7):e35-44. PMC: 3286354. DOI: 10.1182/blood-2011-08-371203. View

Collins R, Verschuer L, Harmon B, Prentice R, Pope J, KERR J . Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol. 1989; 71(3):343-50. DOI: 10.1111/j.1365-2141.1989.tb04290.x. View

Ghiotto F, Fais F, Valetto A, Albesiano E, Hashimoto S, Dono M . Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 2004; 113(7):1008-16. PMC: 379317. DOI: 10.1172/JCI19399. View

Hoogeboom R, Wormhoudt T, Schipperus M, Langerak A, Dunn-Walters D, Guikema J . A novel chronic lymphocytic leukemia subset expressing mutated IGHV3-7-encoded rheumatoid factor B-cell receptors that are functionally proficient. Leukemia. 2012; 27(3):738-40. DOI: 10.1038/leu.2012.238. View

Arvaniti E, Ntoufa S, Papakonstantinou N, Touloumenidou T, Laoutaris N, Anagnostopoulos A . Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Haematologica. 2011; 96(11):1644-52. PMC: 3208682. DOI: 10.3324/haematol.2011.044792. View

Broker B, Klajman A, Youinou P, Jouquan J, Worman C, Murphy J . Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies. J Autoimmun. 1988; 1(5):469-81. DOI: 10.1016/0896-8411(88)90068-6. View

10.

Sthoeger Z, Wakai M, Tse D, Vinciguerra V, Allen S, Budman D . Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med. 1989; 169(1):255-68. PMC: 2189197. DOI: 10.1084/jem.169.1.255. View

11.

Widhopf 2nd G, Rassenti L, Toy T, Gribben J, Wierda W, Kipps T . Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood. 2004; 104(8):2499-504. DOI: 10.1182/blood-2004-03-0818. View

12.

Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen S . Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998; 102(8):1515-25. PMC: 509001. DOI: 10.1172/JCI3009. View

13.

Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T . Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood. 2006; 109(1):259-70. DOI: 10.1182/blood-2006-03-012948. View

14.

Duckworth A, Glenn M, Slupsky J, Packham G, Kalakonda N . Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy. Blood. 2014; 123(21):3277-85. DOI: 10.1182/blood-2013-11-539049. View